References
Abe S, Chiba K, Cirincione B et al (2009) Population pharmacokinetic analysis of linezolid in patients with infectious disease: application to lower body weight and elderly patients. J Clin Pharmacol 49:1071–1078
Cattaneo D, Gervasoni C, Cozzi V et al (2016) Therapeutic drug management of linezolid: a missed opportunity for clinicians? Int J Antimicrob Agents 48:728–731
Cattaneo D, Alffenaar JW, Neely M (2016) Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones. Expert Opin Drug Metab Toxicol 12:533–544
Pea F, Furlanut M, Cojutti P et al (2010) Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis. Antimicrob Agents Chemother 54:4605–4610
Cattaneo D, Orlando G, Cozzi V et al (2013) Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with gram-positive infections. Int J Antimicrob Agents 41:586–589
Matsumoto K, Shigemi A, Takeshita A et al (2014) Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. Int J Antimicrob Agents 44:242–247
Klotz U (2009) Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41:67–76
Parameswaran Nair N, Chalmers L, Bereznicki BJ, et al (2017). Adverse drug reaction-related hospitalizations in elderly Australians: a prospective cross-sectional study in two Tasmanian hospitals. Drug Saf. [Epub ahead of print]
Olivier P, Bertrand L, Tubery M et al (2009) Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging 26:475–482
Laroche ML, Charmes JP, Nouaille Y et al (2007) Is inappropriate medication use a major cause of adverse drug reactions in the elderly? Br J Clin Pharmacol 63:177–186
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This is an independent, no-profit, retrospective study carried out as part of the routine management of patients.
Transparency declarations
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Tinelli, M., Gervasoni, C., Piazza, M. et al. Is it time to revise linezolid dose in elderly patients?. Eur J Clin Pharmacol 73, 1335–1336 (2017). https://doi.org/10.1007/s00228-017-2303-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-017-2303-6